District Court Precludes Defendant from Asserting Invalidity Grounds That It Raised or Could Have Reasonably Raised in IPR Proceeding

May 15, 2017

Reading Time : 2 min

Biscotti initially filed suit against Microsoft on November 26, 2013, on a single patent–the ’182 patent–whose subject matter generally relates to video calling solutions. According to the ’182 patent, the video calling solutions provide, among other benefits, “high performance, high definition video quality, [and] simplified installation.” After the litigation began, Microsoft filed three petition for inter partes review of the asserted claims. The Patent Trial and Appeal Board (PTAB) instituted proceedings on some claims but declined to do so on others.  In April 2015, Microsoft filed three more petitions seeking review of the claims that the PTAB initially declined to institute. These April 2015 petitions were rejected for being time-barred under 35 U.S.C. § 315(b).

The claims of the ’182 patent were upheld in IPR, and, with the litigation stay lifted and the parties approaching their trial date in June 2017, Biscotti moved for partial summary judgment on whether Microsoft was estopped by 35 U.S.C. § 315(e)(2) from presenting certain invalidity defenses.

In ruling on Biscotti’s motion, the court recognized that a petitioner is barred from raising any ground “that [it] raised or reasonably could have raised during that inter partes review.” 35 U.S.C. § 315(e)(2) (emphasis added). The court found that an overly narrow reading of the estoppel provision (and, by extension, an overly broad reading of cases such as Shaw and HP, which applied a narrow reading of the estoppel provision) runs counter to the aims of the AIA by providing a forum to re-litigate arguments that were defeated in an IPR. Shaw Industries Group, Inc. v. Automated Creel Systems, Inc., 817 F.3d 1293, 1300 (Fed. Cir. 2016), cert. denied, (U.S. Oct. 31, 2016); HP Inc. v. MPHJ Technology Inv., LLC, 817 F.3d 1339, 1347 (Fed. Cir. 2016). However, the court also acknowledged due process considerations and the chance to assert the merits of a ground for invalidity in some forum, whether court or the PTAB. See, Douglas Dynamics, LLC v. Meyer Prod. LLC, No. 14-CV-886-JDP, 2017 WL 1382556, at *4 (W.D. Wis. Apr. 18, 2017). With these competing considerations in mind, the court constrained Shaw to its facts, holding that estoppel applied to grounds that were sought and to prior art that was discoverable under the “skilled searcher standard.” Microsoft could still assert grounds for which it petitioned in IPR, but which the PTAB declined to institute for only procedural reasons, such as redundancy.

Biscotti Inc. v. Microsoft Corp, Case No. 2:13-CV-01015-JRG-RSP (E.D. Tex. May 11, 2016).

Share This Insight

Previous Entries

IP Newsflash

July 11, 2025

The Federal Circuit recently reversed a PTAB determination on remand that a patent was obvious over applicant admitted prior art (“AAPA”) in combination with prior art patents, holding that expressly designating AAPA as a “basis” for a ground is improper under 35 U.S.C. § 311(b). In doing so, the Court rejected the PTAB’s “blanket rule” that “AAPA used in combination with prior art patents or printed publications under § 311(b) is ipso facto not the basis or part of the basis of a ground.” Ultimately, while the case clarifies that expressly listing AAPA in an IPR ground is improper, the precise line between proper and improper uses of AAPA in other instances remains unclear.

...

Read More

IP Newsflash

July 1, 2025

In an appeal from an inter partes review, the Federal Circuit recently clarified that the enablement inquiry applied to prior art references in the context of an anticipation defense differs from the enablement inquiry applied when evaluating the claims of a patent.

...

Read More

IP Newsflash

June 26, 2025

The Northern District of Ohio denied a motion to compel the plaintiff to produce test results referenced in its initial disclosures and complaint. The court found that because the “test results are not facts but rather are opinions,” the information was protected as work product. Furthermore, because that testing would not be used as evidence in the litigation, the defendant was not prejudiced.

...

Read More

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.